CRDF Cardiff Oncology, Inc.: institutional ownership and insider trading
111 funds reported holding $39.0M of Cardiff Oncology, Inc. in their latest 13F filings; in Q2 2026 funds net sold $7.99M, with 20 new positions and 30 funds selling out; over the last 12 months insiders bought $1.12M and sold $0 on the open market.
Famous investors holding CRDF
- Ken Griffin (Citadel Advisors): $257K, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $175K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $62.0K, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $18.1K, 0.0% of the portfolio
Largest institutional holders of CRDF
- VANGUARD GROUP INC — $10.5M
- Laurion Capital Management LP — $4.03M
- VANGUARD CAPITAL MANAGEMENT LLC — $3.76M
- PFIZER INC (PFE) — $3.01M
- Nuveen Asset Management, LLC — $2.55M
- FRANKLIN RESOURCES INC (BEN) — $1.57M
- BlackRock, Inc. (BLK) — $1.26M
- BLAIR WILLIAM & CO/IL — $1.19M
- GEODE CAPITAL MANAGEMENT, LLC — $1.07M
- JANE STREET GROUP, LLC — $896K
Recent CRDF insider trades
- Jul 14, 2026: Mohindru Mani bought 34,364 shares ($50.2K)
- Jul 14, 2026: Pace Gary W bought 687,285 shares ($1.00M)
- Jun 18, 2026: Pace Gary W bought 30,000 shares ($36.6K)
- Jun 18, 2026: Mohindru Mani bought 24,703 shares ($29.9K)